Claire Durrant, PhD, Centre for Discovery Brain Sciences, The University of Edinburgh, Edinburgh, UK, discusses the roles of two specific proteins in Alzheimer’s disease (AD) pathology, beta-amyloid and tau. Dr Durrant highlights how both proteins are important targets for future dementia treatments. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).
